Efficacy and Safety of Tenofovir and Entecavir in Patients with Chronic Hepatitis B - Comparative Cohort Study

Journal Title: Journal of Medical Science And clinical Research - Year 2016, Vol 4, Issue 11

Abstract

Background: Hepatitis B virus (HBV) infection is a global problem and >350 million HBV carriers in the world. HBV infection causes chronic hepatitis and can lead to liver cirrhosis and hepatocellular carcinoma (HCC). Aim: To evaluate safety and efficacy of Tenofovir and Entecavir medications in liver disease course in HBVdecompensated cirrhosis patients Patients & Methods: The study was carried out in hepatology Out-Patient Clinic, Amiri hospital, Kuwait. Forty six HBV decompensated cirrhosis patients were classified into 2 groups; Tenofovir group (n=23) and Entecavir group (n=23). All patients underwent clinical examination, laboratory data (liver profile, HBV DNA, eGFR, Phosphate) and Assessment of Child-Pugh (CP) score, Model for end stage liver disease (M ELD) score before and after treatment. Results: Baseline HBV DNA and liver enzymes of both groups showed no significant difference before treatment. 21 (91.3%) of patients of in each group had undetectable HBV DNA at 12 months. CP and MELD scores among the 2 groups showed improvement in both scores after treatment with similar changes in both scores between the 2 medications at any time. Comparison of eGFR among the 2groups showed no changes at any time in eGFR at each group and in between the 2 groups. Conclusion: Both antivirals (Tenofovir and Entecavir) were well tolerated; none of the patients discontinued therapy, while eGFRs were not different between Tenofovir and Entecavir groups during the follow up period, the patients had excellent virological response without viral breakthrough and with improvement in severity of liver disease.

Authors and Affiliations

Dr. Mahmoud A El Tahawy

Keywords

Related Articles

Solitary Plasmacytoma of Scalp without Intra Cranial ExtensionA Cytological Rare Case Report

In this report we present an interesting rare case of solitary plasmacytoma of the scalp without bony erosion in a 52 year female. The clinicians suspected it to be a malignant tumor, but didn’t come to a conclusion as t...

Tuberculous Otitis Media: A Prospective Study

Background: Tuberculosis is a chronic granulomatous disease that can affect any part of the body. Being endemic in India tuberculosis must be included in the differential diagnosis of chronic otitis media not responding...

Post Operative Floating Shoulder Rehabilitation: A Rare Case

We present a case of shoulder instability following a traffic accident. Allman Type I midshaft clavicle, IDEBERG type scapular wing with multiple ribs fractures were diagnosed following radiologic examination. There were...

Fine Needle Aspiration Cytology versus Fine Needle Non Aspiration Cytology-A Comparative Analysis in Various Breast Lesions

FNAC (Fine Needle Aspiration Cytology) is a well established and reliable diagnostic tool. It is considered an important first line procedure for the assessment of various superficial and deepseated lesions. FNAC techniq...

Feasibility of Weekly Cisplatin Versus Gemcitabine Concomitant with Radiation in The Management of Locally Advanced Carcinoma Cervix

Introduction: Cervical cancer is the fourth most common malignancy in women worldwide (1). The study was conducted to evaluate the feasibility, toxicity and response of weekly gemcitabine against the widely accepted week...

Download PDF file
  • EP ID EP214819
  • DOI -
  • Views 59
  • Downloads 0

How To Cite

Dr. Mahmoud A El Tahawy (2016). Efficacy and Safety of Tenofovir and Entecavir in Patients with Chronic Hepatitis B - Comparative Cohort Study. Journal of Medical Science And clinical Research, 4(11), 14010-14017. https://europub.co.uk/articles/-A-214819